Neoleukin Therapeutics Operating Income 2013-2021 | NLTX

Neoleukin Therapeutics operating income from 2013 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Neoleukin Therapeutics Annual Operating Income
(Millions of US $)
2020 $-34
2019 $-71
2018 $-33
2017 $-51
2016 $-38
2015 $-21
2014 $-22
2013 $-9
2012 $-8
Neoleukin Therapeutics Quarterly Operating Income
(Millions of US $)
2021-06-30 $-15
2021-03-31 $-15
2020-12-31 $-13
2020-09-30 $-2
2020-06-30 $-10
2020-03-31 $-9
2019-12-31 $-8
2019-09-30 $-60
2019-06-30 $-0
2019-03-31 $-3
2018-12-31 $-5
2018-09-30 $-15
2018-06-30 $3
2018-03-31 $-15
2017-12-31 $-17
2017-09-30 $-12
2017-06-30 $-14
2017-03-31 $-9
2016-12-31 $-11
2016-09-30 $-8
2016-06-30 $-11
2016-03-31 $-7
2015-12-31 $-6
2015-09-30 $-5
2015-06-30 $-5
2015-03-31 $-6
2014-12-31 $-8
2014-09-30 $-6
2014-06-30 $-6
2014-03-31 $-3
2013-12-31 $-3
2013-09-30 $-3
2013-06-30 $-2
2013-03-31 $-1
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.326B $0.025B
Neoleukin Therapeutics Inc. is a biopharmaceutical company. It is engaged in creating next generation immunotherapies using de novo protein design technology. The company's product candidate consists of NL-201 which is in clinical stage. Neoleukin Therapeutics Inc., formerly known as Aquinox Pharmaceuticals Inc., is based in Seattle, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71